Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Centanni

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonistM Cazzola, B Boveri, P Carlucci, et al.
Respiratory Medicine|December 13, 2005
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflationP Santus, S Centanni, M Verga, et al.
The European Respiratory Journal|August 10, 2010
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonO Kornmann, R Dahl, S Centanni, et al.
Pulmonary Pharmacology & Therapeutics|March 30, 2013
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitisF Blasi, T Schaberg, S Centanni, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2009
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary diseaseP Santus, F Casanova, M L Biondi, et al.
Chest|December 15, 2000
Additive effects of salmeterol and fluticasone or theophylline in COPDM Cazzola, G Di Lorenzo, F Di Perna, et al.
Drugs Under Experimental and Clinical Research|December 8, 2000
Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary dataS Centanni, P Santus, F Casanova, et al.
Pharmacological Research|May 14, 2003
Effects of zafirlukast on bronchial asthma and allergic rhinitisG Piatti, L Ceriotti, G Cavallaro, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1997
Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthmaS Centanni, F Pregliasco, C Bonfatti, et al.
Thorax|August 1, 2002
Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatmentF Blasi, S Damato, R Cosentini, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Pulmonary Pharmacology & Therapeutics|November 4, 2000
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonistM Cazzola, B Boveri, P Carlucci, et al.
Respiratory Medicine|December 13, 2005
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflationP Santus, S Centanni, M Verga, et al.
The European Respiratory Journal|August 10, 2010
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonO Kornmann, R Dahl, S Centanni, et al.
Pulmonary Pharmacology & Therapeutics|March 30, 2013
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitisF Blasi, T Schaberg, S Centanni, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2009
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary diseaseP Santus, F Casanova, M L Biondi, et al.
Chest|December 15, 2000
Additive effects of salmeterol and fluticasone or theophylline in COPDM Cazzola, G Di Lorenzo, F Di Perna, et al.
Drugs Under Experimental and Clinical Research|December 8, 2000
Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary dataS Centanni, P Santus, F Casanova, et al.
Pharmacological Research|May 14, 2003
Effects of zafirlukast on bronchial asthma and allergic rhinitisG Piatti, L Ceriotti, G Cavallaro, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1997
Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthmaS Centanni, F Pregliasco, C Bonfatti, et al.
Thorax|August 1, 2002
Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatmentF Blasi, S Damato, R Cosentini, et al.
Pageof 7